We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
-15.38%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$409M
AUM Growth
-$50.8M
Cap. Flow
+$37.5M
Cap. Flow %
9.18%
Top 10 Hldgs %
90.46%
Holding
22
New
1
Increased
4
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
BBNX
Beta Bionics
BBNX
+$57.9M
2
IOT icon
Samsara
IOT
+$2.55M
3
DDOG icon
Datadog
DDOG
+$2.54M
4
NU icon
Nu Holdings
NU
+$1.69M
5
MNDY icon
monday.com
MNDY
+$431K

Top Sells

Rank Stock Value
1
PATH icon
UiPath
PATH
+$15.3M
2
DASH icon
DoorDash
DASH
+$5.01M
3
SNOW icon
Snowflake
SNOW
+$2.07M
4
CPNG icon
Coupang
CPNG
+$1.89M
5
KVYO icon
Klaviyo
KVYO
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 38.69%
2 Healthcare 21.82%
3 Consumer Discretionary 21.54%
4 Financials 17.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVYO icon
1
Klaviyo
KVYO
$5.26B
$104M 25.48%
3,443,515
-27,179
-0.8% -$1.1M
NU icon
2
Nu Holdings
NU
$73.6B
$73.4M 17.94%
7,164,355
+143,196
+2% +$1.69M
DASH icon
3
DoorDash
DASH
$94B
$69.6M 17.02%
380,704
-26,639
-7% -$5.01M
BBNX
4
Beta Bionics
BBNX
$790M
$38M 9.29%
+3,103,782
New +$57.9M
IKT icon
5
Inhibikase Therapeutics
IKT
$336M
$24M 5.86%
10,950,000
– –
CPNG icon
6
Coupang
CPNG
$29B
$18.5M 4.52%
843,476
-81,236
-9% -$1.89M
MNDY icon
7
monday.com
MNDY
$3.7B
$12.1M 2.97%
49,908
+1,630
+3% +$431K
DDOG icon
8
Datadog
DDOG
$91.7B
$11.7M 2.86%
117,930
+20,142
+21% +$2.54M
IOT icon
9
Samsara
IOT
$23.2B
$9.71M 2.38%
253,432
+54,742
+28% +$2.55M
TARS icon
10
Tarsus Pharmaceuticals
TARS
$3.04B
$8.73M 2.14%
170,000
– –
TOST icon
11
Toast
TOST
$20.1B
$6.99M 1.71%
210,611
-20,919
-9% -$783K
CRWD icon
12
CrowdStrike
CRWD
$221B
$5.49M 1.34%
62,240
-6,160
-9% -$587K
ACRV icon
13
Acrivon Therapeutics
ACRV
$83.6M
$4.31M 1.05%
2,122,605
– –
TXG icon
14
10x Genomics
TXG
$7.31B
$4.21M 1.03%
481,770
– –
PATH icon
15
UiPath
PATH
$8.3B
$4.08M 1%
395,855
-1,188,822
-75% -$15.3M
SNOW icon
16
Snowflake
SNOW
$114B
$3.92M 0.96%
26,828
-12,179
-31% -$2.07M
ABOS icon
17
Acumen Pharmaceuticals
ABOS
$193M
$3.76M 0.92%
3,417,075
– –
BIOA
18
BioAge Labs
BIOA
$487M
$2.96M 0.72%
786,353
– –
CADL icon
19
Candel Therapeutics
CADL
$897M
$2.29M 0.56%
405,837
– –
TSHA icon
20
Taysha Gene Therapies
TSHA
$1.94B
$1.01M 0.25%
724,873
– –
MASS icon
21
908 Devices
MASS
$414M
– –
-237,258
Closed -$522K
SPRB
22
Spruce Biosciences
SPRB
$151M
– –
-9,544
Closed -$301K

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q1 2025 Portfolio in Review

As of Q1 2025, Sands Capital Ventures held 22 positions worth $409M, down 11% from $460M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Sands Capital Ventures deployed $37.5M of net new capital in Q1 2025, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Beta Bionics: 3,103,782 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UiPath, an estimated $15.3M trimmed.

  • Sands Capital Ventures's largest Q1 2025 buy was Beta Bionics: 3,103,782 shares worth $38M.
  • Sands Capital Ventures added most to Samsara in Q1 2025, an estimated $2.55M increase.
  • Sands Capital Ventures's biggest Q1 2025 reduction was UiPath, cutting an estimated $15.3M.
  • Sands Capital Ventures fully exited 908 Devices in Q1 2025, selling an estimated $522K.
  • Sands Capital Ventures's ten largest holdings make up 90% of its $409M portfolio in Q1 2025.
  • Sands Capital Ventures opened 1 new position and closed 2 in Q1 2025.
  • Sands Capital Ventures's portfolio value fell 11% quarter-over-quarter to $409M.

Based on Sands Capital Ventures's 13F filing for Q1 2025, filed 14 May 2025.